Crackdowns on Unproven Stem Cell Therapies Worked Abroad
"While such research faces inevitable limitations in its ability to establish causality, we observed that regulatory actions in both countries were followed by a distinct pattern of change: a reduction in the size of markets, a shift in the types of biologics advertised, and a tempering of marketing claims. " (Leigh Turner)